Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The menopausal transition may represent an inflection point for worsening of multiple sclerosis in women, according to study findings.

A recent study shows that menopause may worsen Multiple Sclerosis symptoms and accelerate its progression due to a decline in ...

A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...

Pregnant women with multiple sclerosis (MS) have a higher risk of mental illness during pregnancy and within the first year after they give birth. | Neuroscience ...

A promising new treatment accelerates myelin repair, potentially restoring vision and improving brain function in people with ...

Each year, a striking difference occurs in Australia when Shepard avocados briefly replace Hass at the shops. Here’s why.

The FDA is adding a new boxed warning to include information that anaphylaxis can occur at any time, from as early as after ...

One year after being acquired by Global Alzheimer’s Platform Innovations, Tampa-based Axiom Brain Health has expanded its ...

The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.